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Abstract: Transcriptome dynamics in the longissimus muscle (LM) of young Angus cattle were evaluated at 0, 60, 120, and 220 days
from early-weaning. Bioinformatic analysis was performed using the dynamic impact approach (DIA) by means of Kyoto Encyclopedia
of Genes and Genomes (KEGG) and Database for Annotation, Visualization and Integrated Discovery (DAVID) databases. Between 0 to
120 days (growing phase) most of the highly-impacted pathways (eg, ascorbate and aldarate metabolism, drug metabolism, cytochrome
P450 and Retinol metabolism) were inhibited. The phase between 120 to 220 days (finishing phase) was characterized by the most
striking differences with 3,784 differentially expressed genes (DEGs). Analysis of those DEGs revealed that the most impacted KEGG
canonical pathway was glycosylphosphatidylinositol (GPI)-anchor biosynthesis, which was inhibited. Furthermore, inhibition of calpastatin and activation of tyrosine aminotransferase ubiquitination at 220 days promotes proteasomal degradation, while the concurrent
activation of ribosomal proteins promotes protein synthesis. Therefore, the balance of these processes likely results in a steady-state of
protein turnover during the finishing phase. Results underscore the importance of transcriptome dynamics in LM during growth.
Keywords: longissimus muscle, intramuscular fat, growth, nutrition
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Background

The application of microarrays for gene expression
profiling of longissimus dorsi skeletal muscle (LM)
of mature beef cattle is relatively new.1–3 Although
useful data were generated from previous studies,
they suffer from low biological replication, lack of
a robust bioinformatics analysis, and were static in
nature as the animals were not sampled throughout their lifespan. Therefore, the dynamism of the
transcriptome of LM from weaning until harvest in
beef cattle remains largely unknown. Such information is valuable to identify cellular adaptations
that may be more susceptible to particular diets
(eg, high-starch vs. high-fiber diets) during a given
stage of growth (eg, the growing phase vs. the finishing phase), and potentially serve as targets for
enhancing the quality and yield grade of the carcass
at slaughter.
In the present study, we performed a comprehensive analysis of the transcriptome as it relates
to the dynamics of canonical pathways and biological functions in LM of Angus steers during a
period when muscle mass accretion predominates,
the growing phase (approximately 120 days from
early weaning), and subsequently during a period
when fat deposition is substantial, the finishing
phase (from the end of the growing phase through to
slaughter), using a novel bioinformatics approach,
the dynamic impact approach (DIA).4,5 The specific
objectives of the present study were to determine
(1) the metabolic pathways most impacted during
the growing and finishing phases; (2) the pathways
that are most impacted and their extent of activation or inhibition; and (3) distinguish the key biological processes that govern the development of
skeletal muscle tissue, including intramuscular fat
deposition. DIA relies on the Kyoto Encyclopedia
of Genes and Genomes (KEGG) database and the
Database for Annotation, Visualization and Integrated Discovery (DAVID). The former was used to
determine the most impacted canonical pathways,
while DAVID was used to determine the most relevant subcategories within the 3 gene ontology
domains (cellular component, molecular function,
and biological processes). The InterPro database of
DAVID was also used to identify domains and functional sites within a protein with high impact in the
analysis.
254

Methods
Experimental animals, diets,
and sampling

Complete details of the animal experiment have
been reported previously.6 Briefly, fourteen purebred
Angus steer calves (7 animals per treatment) from the
University of Illinois, Urbana-Champaign, beef cattle
herd were utilized to examine the effects of two different levels of starch in the diet. Early weaning was
performed at 155 ± 10 days after birth. The steers were
randomly assigned to a high-starch (5,980 kJ/kg diet
DM) or a low-starch (4,970 kJ/kg diet DM) diet for
120 days. At the end of the growing phase, steers on
each group were gradually adapted to a common highgrain finishing diet containing 6,030 kJ calculated
net energy for gain per kg DM. All steers received
an implant of 20 mg oestradiol benzoate and 200 mg
progesterone (Component E-S; Vetlife Inc., West Des
Moines, IA, USA) after the biopsy on day 60. Muscle
biopsies were collected at 0, 60, 120, and 220 days
relative to the start of feeding treatment diets (ie, at
a range in age of 155 ± 10 days). The complete procedures for biopsy, RNA extraction, and microarray
analysis have been reported previously.7,8
Microarrays and data analysis
The details of the microarray platform used and
the hybridization procedure have been reported
previously.5 Data from the microarray analysis were
normalized for dye and microarray effects (ie, Lowess normalization and array centering) and used for
statistical analysis. Data were analyzed using the
Proc MIXED procedure of SAS (SAS, SAS Inst. Inc.,
Cary, NC). Fixed effects were diet, day (0, 60, 120,
220), and dye (Cy3, Cy5). Random effects included
steer and microarray. Raw P values were adjusted
using Benjamini and Hochberg’s false discovery rate
(FDR).9 The microarray data files are deposited at
NCBI (GSE48136).

Dynamic impact approach (DIA)

Bioinformatics analysis of microarray data was performed using DIA10 and information from the freely
available online databases KEGG and DAVID (v6.7).
A list of protein or gene identifiers (Entrez Gene IDs)
was uploaded all at once to extract and summarize
functional annotations associated with groups of
genes or with each individual gene. Details of the
Bioinformatics and Biology Insights 2013:7
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Results

There was no statistically significant effect of treatment therefore the present analysis is centered on the
DIA analysis of differentially expressed genes (DEGs)
due to time. Results for total number of DEGs due
to time are presented in Figure 1. The highest number (P value , 0.05; FDR , 0.01) of downregulated
(1,799) and upregulated (1,985) DEGs was observed
during the finishing phase (220 vs. 120). The lowest
number (P value , 0.05; FDR , 0.01) of DEGs was
observed at 120 vs. 60, with 744 downregulated and
690 upregulated genes. The comparison of DEGs at
the end of the study (day 220) relative to start of the
study resulted in the largest number of DEGs (4,032).
The percentage of DEGs on the microarray platform
which belong to a given pathway, is one of the values
used to calculate the impact.10 This is one reason the
impact of the metabolism KEGG category follows a
similar pattern as the total number of DEGs at each
time comparison (Fig. 1).

Most impacted pathways

When only the growing phase was considered, Ascorbate and aldarate metabolism (Carbohydrate Metabolism subcategory), Drug metabolism—cytochrome
P450 (Xenobiotics Biodegradation and Metabolism
subcategory), and Retinol metabolism (Metabolism
of Cofactors and Vitamins subcategory) were the
most impacted and inhibited pathways. When only
400
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DIA approach and its validation have been reported
previously.5,10
The interpretation of the bioinformatics analysis
was based on results from KEGG pathways focusing on those most impacted. The impact provides an
evaluation of the relative importance of the change
(flux) in a pathway and/or function in response to a
treatment and/or change in physiological state.10 The
most impacted pathways were obtained by evaluating
those pathways with calculated impact values above
50% of the total impact value of the top-impacted
pathway independently at 60 vs. 0 (early growing
phase), 120 vs. 60 (late growing phase), and 220 vs.
120 (finishing phase). It should be noted that this
approach was problematic for data obtained during the finishing phase, 220 vs. 120, because of the
markedly high level of impact for the glycosylphosphatidylinositol (GPI)-anchor biosynthesis KEGG
pathway. Therefore, to avoid a bias, only pathways
at 220 vs. 120 with impact values similar to those
in other time comparisons are discussed (Table 2).
The direction of the impact (flux) was calculated
according to our published procedure,10 considering
negative flux values as inhibited or downregulated
and positive flux values as activated or upregulated.
Additional File 1 contains information on flux and
impact values for each pathway, including the cut-off
impact value above which pathways were considered
most impacted and used for biological interpretation.

−200
60 vs. 0

120 vs. 60

220 vs. 120

220 vs. 0

Time comparison
Figure 1. Impact and direction of the impact of the Metabolism KEGG Category, total number of Differentially Expressed Genes (DEG) due to time on
experiment for each time comparison. Total number of genes = 13,153 (P value , 0.05; FDR , 0.01).
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Figure 2. Direction of the impact (vertical bars, negative values for inhibited pathways and positive values for activated pathways) and impact (dots with
different shapes) for each time comparison for the KEGG category metabolism (P value , 0.05; FDR , 0.01).

the finishing phase was considered (220 vs. 120),
GPI-anchor biosynthesis (Glycan Biosynthesis and
Metabolism subcategory), Pentose and glucuronate
interconversions (Carbohydrate Metabolism subcategory), and Sulfur metabolism (Energy Metabolism
subcategory), in that order, were the most impacted metabolic pathways. The first two pathways were inhibited
while the last one was activated (Table 2). It is important to mention that during the finishing phase, two
glycoproteins present in the GPI-anchor biosynthesis
pathway, glycoprotein phospholipase D (IPR001028
or GPLD1) and phosphatidylinositol glycan anchor
biosynthesis, class Q (PIGQ), were markedly downregulated resulting in the Glycan Biosynthesis and
Metabolism KEGG subcategory having the highest
impact level compared with all other pathways in the
present study (Additional File 1).
Regarding the overall KEGG Metabolism
Category results (220 vs. 0), the Drug MetabolismCytochrome P450 pathway within the Xenobiotics Biodegradation and Metabolism pathway, the
Pentose and glucuronate interconversions pathway
within the Carbohydrate Metabolism pathway,
and the One carbon pool by folate pathway within
the Metabolism of cofactors and vitamins pathway were the most impacted and inhibited. Moreover, Glycosaminoglycan biosynthesis-heparan
sulfate pathway within the Glycan Biosynthesis
and Metabolism pathway, and the Phenylalanine,
256

tyrosine and tryptophan biosynthesis pathway within
the Amino acid Metabolism were the most impacted
and activated (Figs. 3 and 4).
The above results are general, meaning that they
only provide information about the overall impact and
the general direction of the impact (flux) of each significant pathway in the dataset. With the aim to reach
a better understanding about the biological relevance
of each pathway, the present analyses are also focused
on the significant biological processes, molecular
functions, cellular components, and domains and
important sites of proteins (GO-Interpro) within each
significantly impacted pathway.
During the beginning of the growing phase,
in the pathways where cytochromes were present
(Metabolism of xenobiotics by cytochrome P450
and Arachidonic Acid Metabolism), epoxide hydrolases (GO:0004301∼epoxide hydrolase activity) and
Flavin-containing monooxygenase 3 (IPR002255:
Flavin-containing monooxygenase (FMO)) were
inhibited. Moreover, a number of cytochromes that
belong to the Arachidonic Acid Metabolism pathway were activated during the entire growing phase.
Data also suggest that prostaglandin (PG) synthesis (via IPR002972:Prostaglandin D synthase—
Arachidonic Acid Metabolism) was inhibited
during the second half of the growing phase and
was then activated during the finishing phase. In
addition, in the Drug metabolism—cytochrome
Bioinformatics and Biology Insights 2013:7
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Figure 3. Results of the most impacted pathways during the growing phase and finishing phase (220 vs. 0) uncovered by the Dynamic Impact Approach
(DIA) based on Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways database analysis of the bovine muscle transcriptome. Columns represent
the direction of the pathway (green color = inhibition, red color = activation). Continuous black lines show the impact of each pathway (P value , 0.05;
FDR , 0.01).

P450 KEGG pathway during the finishing phase,
Aldehyde oxidase 1 (IPR014313) had a strong activation (Table 3).
The Retinol metabolism pathway and Pantothenate and CoA biosynthesis pathway were the highest
impacted pathways within the subcategory Metabolism
Bioinformatics and Biology Insights 2013:7

of Cofactors and Vitamins during the beginning of the
growing phase (Additional File 1). The Retinol metabolism had a marked inhibition of cytochrome P450
enzymes (IPR008066:Cytochrome P450, E-class,
group I, CYP1) and a wide variety of dehydrogenases (Additional File 2-Interpro and MF 60 vs. 0).
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Figure 4. Results of the most impacted pathways during the growing phase and finishing phase (220 vs. 0) uncovered by the Dynamic Impact Approach
(DIA) based on Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways database analysis of the bovine muscle transcriptome. Columns represent
the direction of the pathway (green color = inhibition, red color = activation). Continuous black lines show the impact of each pathway (P value , 0.05;
FDR , 0.01).

The overall inhibition observed for Pantothenate and
CoA biosynthesis during the first half of the growing
phase was associated primarily with marked downregulation of the pantetheine hydrolase (Vanin-1)
(GO:0017159∼pantetheine hydrolase activity) enzyme
(Table 3, Additional File 1).
Within the Amino acid Metabolism KEGG
subcategory, metabolism of histidine, tyrosine and
258

phenylalanine were the most impacted. Monoamine oxidase B (EC:1.4.3.4 or MAOB) is an enzyme
common to the histidine, tyrosine, and phenylalanine metabolic pathways which produces an evident
inhibition of the tyrosine and phenylalanine pathway
during the early growing phase (Additional File 1).
During the finishing phase, the tyrosine aminotransferase (TAT) (IPR005957) enzyme was strongly
Bioinformatics and Biology Insights 2013:7
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activated, determining a high impact for the Phenylalanine, tyrosine, and tryptophan biosynthesis pathway during this stage. The enzyme gamma-glutamyl
transpeptidase (GGT) (IPR000101) is common to the
Taurine and Hypotaurine Metabolism and Cyanoamino acid Metabolism pathways, both subcategories of
Metabolism of others amino acids. The GGT enzyme,
was inhibited with a high impact during the beginning
of the growing phase (60 vs. 0) and during the finishing phase (220 vs. 120). Moreover, cysteine dioxygenase (CDO1) activity (GO:0017172) was increased
during the finishing phase (Fig. 3 and Table 3).
The Glyoxylate and dicarboxylate metabolism
pathway had inhibition during early growing phase
due to glutamate-ammonia ligase (IPR008146: Glutamine synthetase, catalytic region) and citrate synthase (IPR010109:Citrate synthase, eukaryotic)
downregulation during this period. The Glycolysis/
Gluconeogenesis pathway had the highest impact
during the early growing phase due to inhibition of
the enzymes phosphoenolpyruvate carboxykinase
(PCK1) and alcohol dehydrogenase (ADH). During the
second half of the growing phase, the bioinformatics
analysis identified that synthesis of dihydroxyacetone
phosphate (GO:0004807∼triose-phosphate isomerase
activity) and the glyceraldehyde-3-phosphate metabolic process (GO:0019682) were inhibited, while
the Lactate dehydrogenase activity was upregulated.
Moreover, L-lactate dehydrogenase (GO:0004459∼Llactate dehydrogenase activity, IPR011304:L-lactate
dehydrogenase) and all glycolytic enzymes mentioned above were activated during the finishing
phase. Lastly, Butanoate metabolism was in general
inhibited in the first half of the growing phase due
namely to downregulation of butyrate-CoA ligase
activity (GO:0047760). This enzyme, however, was
upregulated during the second half of the growing
phase (Table 3).

Most recurrent pathways

The Pentose and glucuronate interconversions and
Sulfur Metabolism pathways were the most recurrent pathways in the dataset. They had impact values greater than the cut-off of 50% of the maximum
total impact at all the time comparisons analyzed. The
impact of both pathways was greater during the finishing phase, with a general inhibition of the Pentose and
glucuronate interconversions mainly due to a strong
Bioinformatics and Biology Insights 2013:7

downregulation of UDP-glucose 6-dehydrogenase
(GO:0003979) and a general activation of Sulfur
Metabolism due to a strong upregulation of the Aryl
sulfotransferase activity (GO:0004062) (Table 3).
A potential biological link between Pentose and
glucuronate interconversions and Sulfur Metabolism
was envisaged by the upregulation of estrone sulfotransferase enzyme (120 vs. 60) and by the aryl sulfotransferase enzyme (220 vs. 120).
Flux through the Pentose and glucuronate interconversions KEGG pathway also leads to the production of an important intermediate of the TCA cycle,
alpha-ketoglutarate (2-oxo-glutarate), which, based
on evaluation of the pathway, would appear to have
been reduced. UDP-glucose 6-dehydrogenase that
produces UDP-alpha-D-glucuronate, on the other
hand, was upregulated during the second half of the
growing phase (120 vs. 60). In addition, Pentose and
glucuronate interconversions in conjunction with the
Glycosaminoglycan biosynthesis-heparan sulfate
pathway were activated during the second half of the
growing phase.
Also recurrent in the analysis were Ascorbate and
aldarate metabolism and Fatty acid metabolism during the early growing phase and, with greater impact
at finishing phase, the KEGG pathways Steroid biosynthesis, Drug metabolism—cytochrome P450,
and PPAR signaling pathway. The first three pathways were slightly inhibited while the last two were
activated in the time periods where they had higher
impact values (Additional File 1). During the early
growing phase, Ascorbate and aldarate metabolism
pathway downregulation was mainly due to a UDPglucose 6-dehydrogenase activity and Regucalcin
(IPR008367) inhibition. The Drug metabolism—
cytochrome P450 pathway switches from inhibition
during the growing phase, mainly due to the action of
the xenobiotic-metabolizing enzyme FMO 3, to activation during the finishing phase due to the effect of
Aldehyde oxidase 1 (Table 3).
The PPAR signaling pathway was inhibited during
the early growing phase (60 vs. 0) due to the downregulation of phosphoenolpyruvate carboxykinase
activity (GO:0004611), Adiponectin (bta:282865),
uncoupling protein 1 (mitochondrial, proton carrier) (bta:281561 or UCP1), and solute carrier family 27 (fatty acid transporter), member 2 (EC:6.2.1.3
or SLC27A2). Stearoyl-CoA 9-desaturase activity
259
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(GO:0004768), however, had an extremely high activation during this period (data not shown). During
the finishing phase (220 vs. 120) PPAR targets were
mostly activated, giving signs for activation of lipid
transport (apolipoprotein A-I (APOA1) or apolipoprotein A-I receptor binding (GO:0034191)) and
apolipoprotein A-II (APOA2)), lipogenesis (stearoylCoA desaturase (delta-9-desaturase) (EC:1.14.19.1
or SCD), fatty acids transport (CD36 molecule
(thrombospondin receptor)), β-oxidation carnitine
palmitoyltransferase 1B (muscle) (EC:2.3.1.21 or
CPT1B), carnitine palmitoyltransferase 1C (CPT1C),
acyl-CoA oxidase 2, branched chain (ACOX2) and
acetyl-CoA acyltransferase 1 (ACAA1), adipocyte
differentiation (sorbin and SH3 domain containing 1
(SORBS1) and fatty acid binding protein 4, adipocyte
(FABP4) with an effect on white fat cell differentiation (GO:0050872), and acylglycerol biosynthetic
process (GO:0046463) (Tables 2 and 3).
The Steroid biosynthesis pathway was inhibited
during the finishing phase due to a downregulation
of cholesterol transporter activity (GO:0017127) and
cholesterol synthesis by downregulation of emopamil
binding proteins (IPR007905). The PPAR signaling pathway had a higher impact during the finishing phase as a result of upregulation of leukotriene
biosynthetic process (GO:0019370) (ie, arachidonic
acid), stearoyl-CoA 9-desaturase activity, glycerol
kinase activity (GO:0004370), and acyl-CoA oxidase
activity (GO:0003997) among others (Table 3).
The overall inhibition of Fatty acid Metabolism
during the early growing phase was primarily due
to a marked downregulation of enzymes involved in
the β-oxidation process, GO:0004085∼butyryl-CoA
dehydrogenase activity, IPR006089:Acyl-CoA dehydrogenase, conserved site, and GO:0004022∼alcohol
dehydrogenase (NAD) activity (Additional File 2).
Acyl carnitine transport activation during the beginning of the growing phase is potentially associated
with use of short-chain branched fatty acids in LM
tissue (Additional File 2). This reaction was accompanied by the activation of the mitochondrial AcylCoA dehydrogenase short branched chain (ACADSB)
(Fatty acids Metabolism) and the inhibition of the
others Acyl-CoA dehydrogenases (ACADS, ACADM,
ACADL, ACADVL) and butyryl-CoA ligase (Butanoate
Metabolism). Interestingly, there was a marked upregulation of acyl carnitine transport (GO:0006844∼acyl
260

carnitine transport) during early growing phase. In the
second half of the growing phase, the modest activation of the Fatty acid metabolism pathway was due to
upregulation of the enzyme 3-hydroxyacyl-CoA dehydrogenase (IPR006180:3-hydroxyacyl-CoA dehydrogenase, conserved site) and the general activation
of the Acyl-CoA dehydrogenases. Lastly, a number
of NADPH-generating enzymes, specially alcohol
dehydrogenase (GO:0004022∼alcohol dehydrogenase (NAD) activity) and L-glucuronate reductase
(GO:0047939∼L-glucuronate reductase activity),
were upregulated during the finishing phase.

Other categories

The highest-impact subcategory within Genetic Information Processing was Translation, due to downregulation of expression of the eukaryotic translation
initiation factor 4F complex (GO:0016281) during
the early growing phase and a strong activation during the finishing phase by means of the upregulation
of 50 different ribosomal proteins (Table 1). In contrast, Replication and Repair was highly impacted,
but was inhibited during the finishing phase.
Within the Environmental Information Processing
category, the subcategory Membrane transport had the
highest impact and was inhibited during the finishing
phase due to the inhibition of the ABC transporters
pathway (IPR005951) (Additional File 1). The inhibited Cell communication and Cell motility were the
most impacted Cellular Processes categories, especially during the finishing phase (Table 1).
Within the Organismal Systems category, Sensory system and Development subcategories were
the most impacted during the finishing phase. In particular, Development had a relatively low inhibition
at the beginning of the growing phase and a slight
activation at the second half of the growing phase,
ending with a strong inhibition during the finishing
phase (Additional File 3).
The subcategories of pathways related to Human
Diseases have little to do with bovine LM and will not
be discussed in detail. However, the results indicated
that these pathways were strongly impacted in general
during the finishing phase (Additional File 3).

Discussion

The mechanism of mRNA translation is mediated by
ribosomes and begins with the formation of a ternary
Bioinformatics and Biology Insights 2013:7
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Table 1. Results of flux and impact uncovered by the Dynamic Impact Approach (DIA) based on Kyoto Encyclopedia of
Genes and Genomes (KEGG) Pathways database analysis of the bovine muscle transcriptome for each time comparison.
Category

60 vs. 0

120 vs. 60

220 vs. 120

220 vs. 0

1. Metabolism
1.1. Carbohydrate metabolism
1.2. Energy metabolism
1.3. Lipid metabolism
1.4. Nucleotide metabolism
1.5. Amino acid metabolism
1.6. Metabolism of other amino acids
1.7. Glycan biosynthesis and metabolism
1.8. Metabolism of cofactors and vitamins
1.9. Metabolism of terpenoidsand polyketides
1.10. Biosynthesis of other secondary metabolites
1.11. Xenobiotics biodegradation and metabolism
2. Genetic information processing
   2.1. Transcription
   2.2. Translation
   2.3. Folding, sorting and degradation
   2.4. Replication and repair
3. Environmental information processing
   3.1. Membrane transport
   3.2. Sign transduction
   3.3. Signaling molecules and interaction
4. Cellular processes
   4.1. Transport and catabolism
   4.2. Cell motility
   4.3. Cell growth and death
   4.4. Cell communication
5. Organismal systems
   5.1. Immune system
   5.2. Endocrine system
   5.3. Circulatory system
   5.4. Digestive system
   5.5. Excretory system
   5.6. Nervous system
   5.7. Sensory system
   5.8. Development
   5.9. Environmental adaptation
Notes: Flux represents the direction of each category and the corresponding subcategory (green color = inhibition, yellow color = stable, red color =
activation, with different color intensities according to the level of upregulation or downregulation). Blue lines show the impact of each category and the
corresponding subcategories (P value , 0.05; FDR , 0.01).

complex between amino-acylated initiator methionine tRNA, GTP, and the initiation factor 2.11 In our
study, the cellular metabolic process in which a protein is formed was extremely activated during the finishing phase, denoting signs of LM growth in steers.
The greater number of DEGs observed in the finishing
phase indicates that the skeletal muscle might have
been more physiologically active in comparison with
the growing phase (Fig. 1). This idea is supported by
the fact that Translation was the subcategory within
Genetic Information Processing with the highest
impact, due to the apparent activation of the Ribosome
Bioinformatics and Biology Insights 2013:7

pathway, ie, translation of mRNA appeared more
robust. Under this scenario, the inhibition of ABC
transporters that require ATP hydrolysis to translocate various substrates across membranes would have
spared energy required for translation.12,13

Carbohydrate metabolism

The finding that several pathways related to the KEGG
subcategory Carbohydrate Metabolism had a high
impact and were in general inhibited during the firsthalf of the growing phase (60 vs. 0), reflected potentially novel adaptations of LM tissue during the early
261

262
Ascorbate and aldarate metabolism
Butanoate metabolism
Glycolysis/gluconeogenesis
Pentose and glucuronate
interconversions
Drug metabolism—cytochrome P450
Metabolism of xenobiotics by cytochrome P450
Nitrogen metabolism
Sulfur metabolism
Arachidonic acid metabolism
Fatty acid metabolism
Steroid biosynthesis
Histidine metabolism
Phenylalanine metabolism
Phenylalanine, tyrosine and tryptophan
biosynthesis
Tyrosine metabolism
Cyanoamino acid metabolism
Taurine and hypotaurine metabolism
Glycosylphosphatidylinositol(GPI)-anchor
biosynthesis
Pantothenate and CoA biosynthesis
Porphyrin and chlorophyll metabolism
Retinol metabolism
PPAR signaling pathway

Carbohydrate metabolism
Carbohydrate metabolism
Carbohydrate metabolism
Carbohydrate metabolism

Xenobiotics biodegradation and metabolism
Xenobiotics biodegradation and metabolism

Energy metabolism
Energy metabolism

Lipid metabolism
Lipid metabolism
Lipid metabolism

Amino acid metabolism
Amino acid metabolism
Amino acid metabolism
Amino acid metabolism

Metabolism of other amino acids
Metabolism of other amino acids

Glycan biosynthesis and metabolism

Metabolism of cofactors and vitamins
Metabolism of cofactors and vitamins
Metabolism of cofactors and vitamins

Endocrine system

Impact

Flux

Flux

Impact

120 vs. 60

60 vs. 0
Flux

Impact

220 vs. 120

Notes: Flux represents the direction of each pathway (green color = inhibition, yellow color = stable, red color = activation with different color intensities according to the level of upregulation or
downregulation). Blue lines show the impact of each pathway. This table is a summary of Additional File 1, where the cutoff of 50% of the maximum total impact is pointed out by a continuous
black line.

KEGG pathway

KEGG sub-category

Table 2. Results of flux and impact of the KEGG Pathways with impact value above the 50% of the maximum total impact of each time comparison
(early growing phase (60 vs. 0), late growing phase (120 vs. 60) and finishing phase (220 vs. 120).
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KEGG pathway (60 vs. 0)
Drug metabolism—cytochrome P450
Butanoate metabolism
Glycolysis/gluconeogenesis
Metabolism of xenobiotics by cytochrome P450
Pantothenate and CoA biosynthesis
Pentose and glucuronate interconversions
Ascorbate and aldarate metabolism
Fatty acid metabolism
PPAR signaling pathway
Metabolism of xenobiotics by cytochrome P450
Fatty acid metabolism
PPAR signaling pathway
Steroid biosynthesis
Taurine and hypotaurine metabolism
Cyanoamino acid metabolism
PPAR signaling pathway
Glyoxylate and dicarboxylate metabolism
Fatty acid metabolism
Steroid biosynthesis
Fatty acid metabolism
Glycolysis/gluconeogenesis
KEGG pathway (120 vs. 60)
Sulfur metabolism
Arachidonic acid metabolism
Glycolysis/gluconeogenesis
Glycolysis/gluconeogenesis
Butanoate metabolism
Pantothenate and CoA biosynthesis
Ascorbate and aldarate metabolism
Glycolysis/gluconeogenesis
Glyoxylate and dicarboxylate metabolism
Glyoxylate and dicarboxylate metabolism
PPAR signaling pathway
PPAR signaling pathway
Arachidonic acid metabolism
PPAR signaling pathway
Fatty acid metabolism
PPAR signaling pathway
Arachidonic acid metabolism
Taurine and hypotaurine metabolism
Cyanoamino acid metabolism
Pentose and glucuronate interconversions
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GO:0004304∼estrone sulfotransferase activity
IPR002972:Prostaglandin D synthase
GO:0019682∼glyceraldehyde-3-phosphate metabolic process
GO:0004807∼triose-phosphate isomerase activity
GO:0047760∼butyrate-CoA ligase activity
GO:0017159∼pantetheine hydrolase activity
GO:0003979∼UDP-glucose 6-dehydrogenase activity
IPR008210:Phosphoenolpyruvate carboxykinase, N-terminal
IPR006099:Methylmalonyl-CoA mutase, alpha and beta chain, catalytic
GO:0004108∼citrate (Si)-synthase activity
GO:0006844∼acyl carnitine transport
GO:0048387∼negative regulation of retinoic acid receptor signaling pathway
IPR010497:Epoxide hydrolase, N-terminal
GO:0046463∼acylglycerol biosynthetic process
IPR006180:3-hydroxyacyl-CoA dehydrogenase, conserved site
GO:0050872∼white fat cell differentiation
IPR000101:Gamma-glutamyltranspeptidase
IPR000101:Gamma-glutamyltranspeptidase
IPR000101:Gamma-glutamyltranspeptidase
GO:0004030∼aldehyde dehydrogenase [NAD(P)+] activity

IPR002255:Flavin-containing monooxygenase (FMO) 3
GO:0047760∼butyrate-CoA ligase activity
IPR018091:Phosphoenolpyruvate carboxykinase, GTP-utilising, conserved site
GO:0004301∼epoxide hydrolase activity
GO:0017159∼pantetheine hydrolase activity
GO:0003979∼UDP-glucose 6-dehydrogenase activity
GO:0003979∼UDP-glucose 6-dehydrogenase activity
GO:0004085∼butyryl-CoA dehydrogenase activity
GO:0046463∼acylglycerol biosynthetic process
IPR002328:Alcohol dehydrogenase, zinc-containing, conserved site
GO:0006844∼acyl carnitine transport
GO:0006844∼acyl carnitine transport
GO:0060695∼negative regulation of cholesterol transporter activity
IPR000101:Gamma-glutamyltranspeptidase
IPR000101:Gamma-glutamyltranspeptidase
GO:0004768∼stearoyl-CoA 9-desaturase activity
IPR008146:Glutamine synthetase, catalytic region
GO:0004022∼alcohol dehydrogenase (NAD) activity
GO:0006707∼cholesterol catabolic process
IPR006089:Acyl-CoA dehydrogenase, conserved site
GO:0004459∼L-lactate dehydrogenase activity

GO: BP/MF/CC/IPR

Impact

(Continued)

Flux

Table 3. KEGG pathways and DAVID Biological Process (BP), Molecular Function (MF), Cellular Component (CC), or Interpro (IPR) for early growing
phase (60 vs. 0), late growing phase (120 vs. 60) and finishing phase (220 vs. 120).
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KEGG pathway (220 vs. 120)
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis
Phenylalanine, tyrosine and tryptophan biosynthesis
Pentose and glucuronate interconversions
Sulfur metabolism
Pantothenate and CoA biosynthesis
Arachidonic acid metabolism
Phenylalanine, tyrosine and tryptophan biosynthesis
Phenylalanine, tyrosine and tryptophan biosynthesis
Drug metabolism—cytochrome P450
Retinol metabolism
Pantothenate and CoA biosynthesis
PPAR signaling pathway
Steroid biosynthesis
PPAR signaling pathway
Fatty acid metabolism
Taurine and hypotaurine metabolism
PPAR signaling pathway
PPAR signaling pathway
Fatty acid metabolism
PPAR signaling pathway
Cyanoamino acid metabolism

Table 3. (Continued)

IPR001028:Glycoprotein phospholipase D
IPR001259:Proteinase inhibitor I27, calpastatin
GO:0003979∼UDP-glucose 6-dehydrogenase activity
GO:0004062∼aryl sulfotransferase activity
IPR003231:Acyl carrier protein (ACP)
IPR002972:Prostaglandin D synthase
GO:0045098∼type III intermediate filament
IPR011715:Tyrosine aminotransferase ubiquitination region
IPR014313:Aldehyde oxidase
IPR008066:Cytochrome P450, E-class, group I, CYP1
IPR006162:Phosphopantetheine attachment site
GO:0004768∼stearoyl-CoA 9-desaturase activity
GO:0017127∼cholesterol transporter activity
GO:0046463∼acylglycerol biosynthetic process
GO:0004022∼alcohol dehydrogenase (NAD) activity
GO:0017172∼cysteine dioxygenase activity
GO:0019370∼leukotriene biosynthetic process
GO:0050872∼white fat cell differentiation
IPR016163:Aldehyde dehydrogenase, C-terminal
GO:0003997∼acyl-CoA oxidase activity
GO:0003840∼gamma-glutamyltransferase activity

GO: BP/MF/CC/IPR

Flux

Impact

Moisá et al

Bioinformatics and Biology Insights 2013:7

Muscle transcriptomics during growth

stages of rapid growth. For instance, the Ascorbate and
aldarate metabolism and the Pentose and Glucuronate
Interconversions pathways were identified as affected
due to the fact that regucalcin and UDP-glucose
6-dehydrogenase (GO:0003979 or UDPGDH) had a
considerable downregulation in expression level in
both pathways. That result highlights two biological
mechanisms which could affect myogenesis during the
early growing phase. Regucalcin leads to activation
of proteolysis14 and the general inhibition of Pentose
and glucuronate interconversions was mainly due to
a strong downregulation of UDPGDH, which might
have reduced the conversion of UDP-glucose into
UDP-glucuronate, a nucleoside diphosphate sugar
with a central role in glycogen biosynthesis in skeletal muscle.15,16 Therefore, UDPGDH inhibition might
have led to greater glycogen synthesis and regucalcin
inhibition might have had a positive effect on protein synthesis during the early growing phase and the
finishing phase. Both biological mechanisms could
serve as signals for LM muscle growth in beef steers
especially during the early growing phase.
The fact that the Glycolysis/Gluconeogenesis pathway was significantly impacted during the early growing phase reflects the metabolic activity in cells within
the LM, including myocytes and intramuscular fat.
Within this pathway, the enzyme phosphoenolpyruvate
carboxykinase (PCK1), inhibited at this stage, is important for gluconeogenesis in liver and for glyceroneogenesis in adipose and muscle tissue17 as it catalyzes the
conversion of oxaloacetate to phosphoenolpyruvate.
The pathway was in general inhibited during the early
growing phase, switching to an active state during the
late growing and finishing phases. Therefore, from a
biological standpoint, the later changes in PCK1 were
likely related to the synthesis of glycerol-3-phosphate
needed for triacylglycerol formation within the intramuscular adipocyte,15 a process that is expected to be
more active during the finishing phase.
The upregulation of L-lactate dehydrogenase
(GO:0004459∼L-lactate dehydrogenase activity)
during the finishing phase is consistent with the
concept that lactate is an important lipogenic substrate in bovine intramuscular fat,16 and could have
been related with greater use of rumen-derived lactate for fatty acids synthesis.18 Moreover, activation
of L-glucuronate reductase, an NADPH-generating
enzyme during the finishing phase, was probably an
Bioinformatics and Biology Insights 2013:7

adaptation of LM tissue (intramuscular adipose) to
sustain greater rates of fatty acids synthesis.18

Amino acid metabolism

Gamma glutamyl transpeptidase (GGT) is an
enzyme within the Taurine and Hypotaurine metabolism and Cyanoamino acid metabolism pathways
with a significant impact during the early growing
phase in this study. The role of GGT is key in the
synthesis and degradation of extracellular glutathione (GSH),19 LDL oxidation,20 and xenobiotic
detoxification.21 Its activity is important for amino
acid transport across cellular membranes.22 During
amino acid transport across cellular membranes,
Gamma-Glutamyl moieties of GSH are hydrolyzed
and transferred to other amino acids, leading to the
formation of gamma-glutamyl amino acids, which
are then transported into the cell.23 Therefore, the
cleavage of the gamma-glutamyl bond of extracellular GSH allows cells to use this antioxidant compound as a source of cysteine for increased synthesis
of intracellular GSH.24
The recovery of cysteine, mediated by GSH
metabolism, becomes critical for protein synthesis. In
contrast, high levels of cysteine are relatively toxic
in the body.23 Cysteine catabolism is tightly adjusted
via regulation of cysteine dioxygenase (CDO1) levels in the liver.25 Additionally, GSH depletion led to
sustained activation of NF-kB (nuclear factor kappalight-chain-enhancer of activated B cells), which
inhibits myogenesis.14 Our results emphasize that, on
one hand, the activation of GSH synthesis after the
early growing phase could have signaled greater activation of amino acid transport into cells for protein
synthesis while, on the other hand, during the finishing phase, cysteine is catabolized by CDO1 likely
to control intracellular cysteine levels partly to prevent of the occurrence of oxidative stress during a
physiological period when intracellular fat deposition
increases.26
Monoamine oxidase B (MAOB) is an enzyme
common to the histidine, tyrosine, and phenylalanine metabolic pathways. Its inhibition during the
early growing phase might have been associated
with lower insulin-like stimulation of glucose transport in adipocytes by means of the monoamine oxidase-dependent oxidation of tyramine.41,42 Amine
oxidation of tyramine by MAOB (IPR002938) leads
265

Moisá et al

to the production of hydrogen peroxide (H2O2), a
well-known insulin-like agent that enhances glucose
transport.27 Our results revealed that during the late
growing phase, this glucose transport blockage was
established potentially to regulate the increase of glucose influx into the cells (Additional File 2).6
Insulin-dependent TAT activation28,29 seems to
be an important mechanism controlling amino acid
metabolism during the early growing and the finishing phases. TAT was highly activated as its ubiquitination region (IPR011715) was upregulated
(Additional File 2). TAT contains two phosphorylation sites, including CAPK at Ser29, and a casein
kinase II site.30 This ubiquitin-dependent degradation
of TAT might explain why the negative regulation of
proteasomal ubiquitin-dependent protein catabolic
process (GO:0032435) was the biological process
which had the highest inhibition during the finishing
phase.
There were two mechanism which could explain
this targeted proteasomal degradation: (a) Desmin, a
type III intermediate filament (GO:0045098) important in muscle cell architecture and structure,31 was
extremely inhibited during the finishing phase; and
(b) Calpastatin, an inhibitor of a calcium-dependent
cysteine protease called Calpain,32 was activated during the finishing phase (Additional File 2). Calpains
plays a key role in post-mortem tenderization of meat
and may be involved in muscle protein degradation
in living tissue.33 These mechanisms were suggestive
of signs of degradation or destabilization of the muscular structure.

Glycan biosynthesis and metabolism

The highly-impacted inhibition of GPI-anchor biosynthesis pathway in our study agrees with previous
results.5 GPI anchor is a glycolipid that can be attached
to the C-terminus of a protein during posttranslational
modification.34 In adipose tissue, GPI-anchored proteins bind to Caveolins by a mechanism known as
palmitoylation.35 Caveolins are a family of integral
membrane proteins which are the principal components of caveolae membranes and they are involved in
receptor-independent endocytosis.36 Caveolae, a special type of lipid raft, are a small invagination of the
plasma membrane and is the place were insulin receptors are localized in adipocytes. Caveolae are mainly
formed and maintained by caveolins. Caveolins are
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synthesized as monomers and transported to Golgi
apparatus. During their transport through secretory
pathway, caveolins associate with lipid rafts, where
GPI-linked proteins are preferentially located, and
form oligomers. These oligomerized caveolins then
form the caveolae.37
The presence of caveolins leads to the local change
in morphology of the membrane.38 Expression of
palmitoylated caveolins is required for the efficient
transport of GPI-linked proteins from the Golgi complex to the plasma membrane.35 Caveolins interact
with the catalytic subunit of protein kinase A (PKA)
and inhibit cyclic AMP (cAMP)-mediated signal
transduction in vivo.39 When PKA-dependent phosphorylation is inhibited, it leads to impaired access
of triacylglycerol lipases such as hormone-sensitive
lipase.40 During the finishing phase, although there
were signs that the PKA gene was being transcribed
(Tie2 Ig-like domain 1, N-terminal (IPR018941) activation), caveolins were not expressed (Additional
File 2). This is potentially due to a marked downregulation of GPI specific phospholipase (GPLD1)
and phosphatidylinositol glycan anchor biosynthesis, class Q (PIGQ) (Table 3) which contributed to
the general inhibition of the GPI-anchor biosynthesis
pathway.
Palmitoylated caveolins by GPI-anchor proteins
are needed to create a blockage in the cAMP-toadenosine conversion associated with lipid droplet
hydrolysis. The end result of this mechanism due to
the inhibition of GPI-anchor proteins would therefore
be the inhibition of lipolysis41 during the finishing
phase. In conclusion, the general inhibition of this
pathway during the finishing phase could have been
associated with promoting lipid droplet accumulation
within intramuscular fat.

Xenobiotics biodegradation
and metabolism

Enzymes in the Drug metabolism—cytochrome P450
pathway catalyze the oxidation of xenobiotics.42
Aldehyde oxidase 1 (AOX1) was activated with a high
impact during the finishing phase. This enzyme is
involved in the process of detoxification of aldehydes
by oxidizing them to produce reactive oxygen species (ROS). When endogenous antioxidant defenses
are inadequate to maintain ROS production in equilibrium, the likelihood of oxidative damage to DNA,
Bioinformatics and Biology Insights 2013:7
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lipids, proteins, and other molecules increases.43 In
this study, data suggest that ROS production was
countered by the upregulation of a thiol specific antioxidant (IPR000866) (Additional File 2).44 Moreover,
a previous study provided evidence that AOX1 could
be involved in adipogenesis29 due to the fact that
AOX1 catalyzes the oxidation of vitamin A aldehyde
to retinoic acid which influences adipocyte differentiation. Therefore it could be possible that AOX1
plays dual roles in LM. Additional studies must be
performed to verify these putative roles.
In the context of adipogenesis, the marked
inhibition
of
cytochrome
P450
enzymes
(IPR008066:Cytochrome P450, E-class, group I,
CYP1) could also have had an effect on the production of all-trans retinoic acid,45 which was likely
associated with the general inhibition of Retinol
Metabolism during the early growing and finishing
phases. Retinoids regulate metabolism by activating
specific nuclear receptors like retinoic acid receptor (RAR) and retinoid X receptor (RXR). RXR heterodimerizes with peroxisome proliferator-activated
receptor gamma (PPARG) leading to a regulation of
adipogenic transcriptional machinery.46

Lipid metabolism

Cytosolic epoxide hydrolases within the Arachidonic Acid Metabolism pathway are induced only
by xenobiotics, which also cause peroxisome proliferation.47 During the early growing phase, cytochrome P450, family 2, subfamily c (EC:1.14.14.1
or CYP2C) activity was inhibited, leading to a
blockage in the production of epoxyeicosatrienoic
acid (EET) from arachidonic acid by cytochrome
P450 epoxygenases (IPR010497:Epoxide hydrolase, N-terminal).48 Support for an intracellular
mechanism of action stems from the fact that EETs
have many characteristics of long-chain fatty acids,
therefore, they are incorporated into cellular membrane phospholipids and bind to cytoplasmic FABPs
and PPARG.49,50
During the second half of the growing phase, the
conversion of arachidonic acid to EET was activated,
while the soluble epoxide hydrolase (EDHX2) was
inhibited, likely leading to EET production during this
stage. Interestingly, during the finishing phase the data
obtained suggest that flux through this pathway led to
greater conversion of EET to dihydroxyeicosatrienoic
Bioinformatics and Biology Insights 2013:7

acids (DHETs), suggesting the presence of soluble
epoxide hydrolases and a potential probability of
increase in the proportion of mesenchymal stem cellderived adipocytes.51 With the above mechanisms in
mind, it could be speculated that EET have a role in
adipogenesis. More studies are required, however, to
verify this hypothesis. On other hand, the fact that
PGs (IPR002972) were upregulated during the finishing phase (Additional File 2) suggested utilization
of arachidonic acid via cyclooxygenases to produce PGs.52 In turn, PGs could have served as activators of PPARG, which is implicated in adipocyte
differentiation.53
The inhibition of mitochondrial β-oxidation
during the early growing phase was likely a result
of lower acyl carnitine transport54,55 in place of
the preferential channeling of long-chain fatty
acids towards acylglycerol formation and adipocyte differentiation. The inhibition of the carnitine
shuttle, as well as the activation of biosynthesis
of acylglycerols, were indicative that esterification was one of the predominant processes during
the finishing phase. Moreover, within the Metabolism of cofactors and vitamins KEGG subcategory,
Vanin-1, present in the Pantothenate and CoA biosynthesis pathway, dictates the high impact for this
pathway. Vanin-1 is a GPI-anchored pantetheinase
which leads to the conversion of Pantetheine to
Pantothenate.56 The 4-phosphopantetheine moiety, linked via its phosphate group to the hydroxyl
group of serine, represents an active component of
the acyl carrier protein (ACP) (IPR003231:Acyl
carrier protein (ACP)) which is a central component of the fatty acid synthase reaction.42 Data
from this study suggest that during the finishing
phase, the phosphopantetheine attachment site of
the ACP (IPR006162:Phosphopantetheine attachment site) was activated, hence facilitating the flux
of carbon source through lipogenesis to generate
intramuscular fat. Within the Endocrine System
KEGG subcategory, the PPARG Signaling Pathway
responses observed were expected based on previous results,57,58 demonstrating that intramuscular
fat deposition in LM increases progressively over
time.59 These combined results explain the temporal increase in the activation of the highly-impacted
differentiation of white fat cells (GO:0050872) and
biosynthesis of acylglycerols (GO:0046463).
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Conclusions

The bioinformatics analyses uncovered highlyimpacted biological processes and metabolic pathways, some of which are associated with glycogen
synthesis in myocytes, some with muscle growth regulation, and others with lipid droplets. These KEGG
pathways analyzed by the DIA approach must
be studied in more detail to aid in the discovery
of new molecular markers for improving carcass
characteristics.
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